医学
传统PCI
冠状动脉疾病
心脏病学
内科学
安慰剂
疾病
心肌梗塞
病理
替代医学
作者
Florentina Simader,Christopher Rajkumar,Michael Foley,Fiyyaz Ahmed‐Jushuf,Shayna Chotai,Nina Bual,A. M. Khokhär,Aisha Gohar,Ioannis Lampadakis,Sashiananthan Ganesananthan,Rachel H. Pathimagaraj,Alexandra N. Nowbar,John R. Davies,Tom R. Keeble,Peter O’Kane,Peter Haworth,Helen Routledge,Tushar Kotecha,James C. Spratt,Rupert Williams
标识
DOI:10.1016/j.jacc.2024.04.016
摘要
Placebo-controlled evidence from ORBITA-2 found that percutaneous cutaneous intervention (PCI) in stable coronary artery disease with little or no antianginal medication relieved angina, but residual symptoms persisted in many. The reason for this was unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI